JPS5649394A - Preparation of blood coagulation factor 5, and determination of abnormal prothrombinase activity - Google Patents
Preparation of blood coagulation factor 5, and determination of abnormal prothrombinase activityInfo
- Publication number
- JPS5649394A JPS5649394A JP12401379A JP12401379A JPS5649394A JP S5649394 A JPS5649394 A JP S5649394A JP 12401379 A JP12401379 A JP 12401379A JP 12401379 A JP12401379 A JP 12401379A JP S5649394 A JPS5649394 A JP S5649394A
- Authority
- JP
- Japan
- Prior art keywords
- prothrombinase activity
- abnormal
- blood coagulation
- prothrombinase
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010000499 Thromboplastin Proteins 0.000 title abstract 8
- 102000002262 Thromboplastin Human genes 0.000 title abstract 8
- 230000000694 effects Effects 0.000 title abstract 8
- 230000002159 abnormal effect Effects 0.000 title abstract 3
- 108010039209 Blood Coagulation Factors Proteins 0.000 title abstract 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 title abstract 2
- 239000003114 blood coagulation factor Substances 0.000 title abstract 2
- 229940019700 blood coagulation factors Drugs 0.000 title abstract 2
- 108010014172 Factor V Proteins 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 150000002772 monosaccharides Chemical class 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 208000031169 hemorrhagic disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12401379A JPS5649394A (en) | 1979-09-28 | 1979-09-28 | Preparation of blood coagulation factor 5, and determination of abnormal prothrombinase activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12401379A JPS5649394A (en) | 1979-09-28 | 1979-09-28 | Preparation of blood coagulation factor 5, and determination of abnormal prothrombinase activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5649394A true JPS5649394A (en) | 1981-05-02 |
Family
ID=14874857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12401379A Pending JPS5649394A (en) | 1979-09-28 | 1979-09-28 | Preparation of blood coagulation factor 5, and determination of abnormal prothrombinase activity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5649394A (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2585035A1 (fr) * | 1985-07-22 | 1987-01-23 | Asahi Chemical Ind | Procede d'analyse de precurseurs d'enzyme et dispositif a utiliser dans ce but |
| JPH05260998A (ja) * | 1992-03-19 | 1993-10-12 | Nitto Boseki Co Ltd | 異常プロトロンビンの測定方法 |
| WO2012143507A1 (en) | 2011-04-22 | 2012-10-26 | Kedrion S.P.A. | Novel process for the preparation of a virus-inactivated fv concentrate starting from human plasma, scalable to industrial level |
-
1979
- 1979-09-28 JP JP12401379A patent/JPS5649394A/ja active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2585035A1 (fr) * | 1985-07-22 | 1987-01-23 | Asahi Chemical Ind | Procede d'analyse de precurseurs d'enzyme et dispositif a utiliser dans ce but |
| JPH05260998A (ja) * | 1992-03-19 | 1993-10-12 | Nitto Boseki Co Ltd | 異常プロトロンビンの測定方法 |
| WO2012143507A1 (en) | 2011-04-22 | 2012-10-26 | Kedrion S.P.A. | Novel process for the preparation of a virus-inactivated fv concentrate starting from human plasma, scalable to industrial level |
| US8822643B2 (en) | 2011-04-22 | 2014-09-02 | Kedrion S.P.A. | Process for the preparation of a virus-inactivated FV concentrate starting from human plasma, scalable to industrial level |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schoelmerich et al. | Zinc and vitamin A deficiency in patients with Crohn's disease is correlated with activity but not with localization or extent of the disease | |
| Terepka et al. | The ultrafiltrable calcium of human serum. II. Variations in disease states and under experimental conditions | |
| e Castro et al. | Hemolytic activity of thionin from Pyrularia pubera nuts and snake venom toxins of Naja naja species: Pyrularia thionin and snake venom cardiotoxin compete for the same membrane site | |
| Von Voss et al. | Sodium valproate and platelet function. | |
| ATE25690T1 (de) | Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems. | |
| Yeh et al. | Ticlopidine-associated aplastic anemia: a case report and review of literature | |
| DE2734427B2 (de) | Verfahren zur Gewinnung von thrombinartigen Enzymen aus Schlangengiften | |
| JPS5649394A (en) | Preparation of blood coagulation factor 5, and determination of abnormal prothrombinase activity | |
| Kench et al. | Haemopoiesis in lead poisoning | |
| Lochhead et al. | The enzymic formation of haem by human and rat tissues | |
| Allan et al. | Urinary zinc in hepatic cirrhosis | |
| Heyes et al. | The appearance of schistocytes in the peripheral blood in correlation to degree of disseminated intravascular coagulation | |
| Stern et al. | Peptidase activity in leucocytes, erythrocytes and plasma of young adult and senile subjects | |
| JPS5569595A (en) | Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation | |
| Schiffmann et al. | In vitro calcification of rat aorta in serum | |
| Klemperer | Hereditary deficiency of the second component of complement in man: an immunochemical study | |
| Cooper et al. | Some endogenous parathyroid hormone effects manifested by bone in vitro. | |
| Chryssanthou et al. | Effect of trypsin inhibitors on Shwartzman phenomenon. | |
| Ninnemann et al. | Hemolysis and suppression of neutrophil chemotaxis by a low molecular weight component of human burn patient sera | |
| Madinaveitia | Studies on diffusing factors: Comparison of diffusing factors from different sources and preparation of concentrates from bull testicle | |
| Heatley et al. | Some experiments on intrinsic factor | |
| Nielsen et al. | On the pathogenetic role of prostaglandins in Bartter's syndrome. | |
| JPS57150382A (en) | Purification of super oxide dismutase | |
| Richert et al. | Vitamin E deficiency and xanthine oxidase in rabbits. | |
| Heideman et al. | Impaired host defence for infections due to complement consumption by tissues changed by heat |